Swecure AB
Prophylactic allergy prevention
This article was originally published in Start Up
Executive Summary
There are many treatments on the market and in development that ease the symptoms of allergies, from antihistamines to immunotherapies, but there is no real prevention or cure. Swedish biotech Swecure AB aims to prevent the development of allergies in the first place: its research is based on a bacterial protein, known as a superantigen, found in the gut flora of newborn babies.
You may also be interested in...
Biopharma In Sweden: A Comfortable Climate For Start-Ups
Sweden’s biopharmaceutical and life sciences industry now makes up a key part of the country's economy, and the climate is ripe for biotech start-ups.
Biopharma In Sweden: A Comfortable Climate For Start-Ups
Sweden’s biopharmaceutical and life sciences industry now makes up a key part of the country's economy, and the climate is ripe for biotech start-ups. Profiles of Northern Light Pharmaceuticals AB, Sigrid Therapeutics, and Swecure AB.
Gadeta BV: Using T-Cells To Target Metabolic Dysregulation In Cancer
Emerging Company Profile: Gadeta, a Dutch spin-out from University Medical Centre Utrecht, launched earlier this year to develop modified T-cell-based therapies that target metabolic dysregulation in solid and hematological malignancies.